Margaret L Dahn - JoVE Visualize

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Oncogene|September 9, 2024

ALDH1A3 is the switch that determines the balance of ALDH+ and CD24-CD44+ cancer stem cells, EMT-MET, and glucose metabolism in breast cancerWasundara Fernando, Brianne M Cruickshank, Raj Pranap Arun, et al.

Molecular Oncology|September 27, 2023

ALDH1A3 promotes invasion and metastasis in triple-negative breast cancer by regulating the plasminogen activation pathwayAlamelu G Bharadwaj, Meghan E McLean, Margaret L Dahn, et al.

Biomarker Research|October 29, 2025

THSD4 is a novel mediator of T cell exclusion and anti-PD-1 resistance in hormone receptor-positive breast cancerOlivia L Walker, Marie-Claire D Wasson, Vishnupriyan Kumar, et al.

Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Oncogene|September 9, 2024

ALDH1A3 is the switch that determines the balance of ALDH+ and CD24-CD44+ cancer stem cells, EMT-MET, and glucose metabolism in breast cancerWasundara Fernando, Brianne M Cruickshank, Raj Pranap Arun, et al.

Molecular Oncology|September 27, 2023

ALDH1A3 promotes invasion and metastasis in triple-negative breast cancer by regulating the plasminogen activation pathwayAlamelu G Bharadwaj, Meghan E McLean, Margaret L Dahn, et al.

Biomarker Research|October 29, 2025

THSD4 is a novel mediator of T cell exclusion and anti-PD-1 resistance in hormone receptor-positive breast cancerOlivia L Walker, Marie-Claire D Wasson, Vishnupriyan Kumar, et al.

Pageof 2